4th Generation Chimeric Antigen Receptor T Cells Targeting Glypican-3

Clinical trial NCT03980288 · COMPLETED

Trial details

NCT number: NCT03980288
Sponsor: Zhejiang University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Hepatocellular Carcinoma

Start date: 2019-07-23
Primary completion: 2020-12-30
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.